Statistics by Country for Gall Bladder Cancer
|
About these extrapolations of prevalence and incidence statistics for Gall Bladder Cancer:
These statistics are calculated extrapolations of various prevalence or incidence rates
against the populations of a particular country or region.
The statistics used for prevalence/incidence of Gall Bladder Cancer are typically based on US, UK, Canadian or Australian statistics.
This extrapolation calculation is automated and does not take into account any genetic, cultural, environmental, social, racial or other differences
across the various countries and regions for which the extrapolated Gall Bladder Cancer statistics below refer to.
As such, these extrapolations may be highly inaccurate (especially for developing or third-world countries) and only give a general indication (or even a meaningless indication)
as to the actual prevalence or incidence of Gall Bladder Cancer in that region.
About prevalence and incidence statistics in general for Gall Bladder Cancer: The word 'prevalence' of Gall Bladder Cancer usually means the estimated population of people who are managing Gall Bladder Cancer at any given time (i.e. people with Gall Bladder Cancer). The term 'incidence' of Gall Bladder Cancer means the annual diagnosis rate, or the number of new cases of Gall Bladder Cancer diagnosed each year (i.e. getting Gall Bladder Cancer). Hence, these two statistics types can differ: a short disease like flu can have high annual incidence but low prevalence, but a life-long disease like diabetes has a low annual incidence but high prevalence. For more information see about prevalence and incidence statistics. |
Incidence (annual) of Gall Bladder Cancer: 7,100 annual cases (SEER 2002 estimate: gallbladder and other biliary)
Incidence Rate for Gall Bladder Cancer: approx 1 in 38,309 or 0.00% or 7,100 people in USA [about data]
Extrapolation of Incidence Rate for Gall Bladder Cancer to Countries and Regions: The following table attempts to extrapolate the above incidence rate for Gall Bladder Cancer to the populations of various countries and regions. As discussed above, these incidence extrapolations for Gall Bladder Cancer are only estimates and may have limited relevance to the actual incidence of Gall Bladder Cancer in any region:
| Country/Region | Extrapolated Incidence | Population Estimated Used |
| Gall Bladder Cancer in North America (Extrapolated Statistics) | ||
| USA | 7,665 | 293,655,4051 |
| Canada | 848 | 32,507,8742 |
| Gall Bladder Cancer in Europe (Extrapolated Statistics) | ||
| Austria | 213 | 8,174,7622 |
| Belgium | 270 | 10,348,2762 |
| Britain (United Kingdom) | 1,573 | 60,270,708 for UK2 |
| Czech Republic | 32 | 1,0246,1782 |
| Denmark | 141 | 5,413,3922 |
| Finland | 136 | 5,214,5122 |
| France | 1,577 | 60,424,2132 |
| Greece | 277 | 10,647,5292 |
| Germany | 2,151 | 82,424,6092 |
| Iceland | 7 | 293,9662 |
| Hungary | 261 | 10,032,3752 |
| Liechtenstein | 0 | 33,4362 |
| Ireland | 103 | 3,969,5582 |
| Italy | 1,515 | 58,057,4772 |
| Luxembourg | 12 | 462,6902 |
| Monaco | 0 | 32,2702 |
| Netherlands (Holland) | 425 | 16,318,1992 |
| Poland | 1,008 | 38,626,3492 |
| Portugal | 274 | 10,524,1452 |
| Spain | 1,051 | 40,280,7802 |
| Sweden | 234 | 8,986,4002 |
| Switzerland | 194 | 7,450,8672 |
| United Kingdom | 1,573 | 60,270,7082 |
| Wales | 76 | 2,918,0002 |
| Gall Bladder Cancer in the Balkans (Extrapolated Statistics) | ||
| Albania | 92 | 3,544,8082 |
| Bosnia and Herzegovina | 10 | 407,6082 |
| Croatia | 117 | 4,496,8692 |
| Macedonia | 53 | 2,040,0852 |
| Serbia and Montenegro | 282 | 10,825,9002 |
| Gall Bladder Cancer in Asia (Extrapolated Statistics) | ||
| Bangladesh | 3,689 | 141,340,4762 |
| Bhutan | 57 | 2,185,5692 |
| China | 33,903 | 1,298,847,6242 |
| East Timor | 26 | 1,019,2522 |
| Hong Kong s.a.r. | 178 | 6,855,1252 |
| India | 27,801 | 1,065,070,6072 |
| Indonesia | 6,224 | 238,452,9522 |
| Japan | 3,323 | 127,333,0022 |
| Laos | 158 | 6,068,1172 |
| Macau s.a.r. | 11 | 445,2862 |
| Malaysia | 614 | 23,522,4822 |
| Mongolia | 71 | 2,751,3142 |
| Philippines | 2,251 | 86,241,6972 |
| Papua New Guinea | 141 | 5,420,2802 |
| Vietnam | 2,157 | 82,662,8002 |
| Singapore | 113 | 4,353,8932 |
| Pakistan | 4,155 | 159,196,3362 |
| North Korea | 592 | 22,697,5532 |
| South Korea | 1,259 | 48,233,7602 |
| Sri Lanka | 519 | 19,905,1652 |
| Taiwan | 593 | 22,749,8382 |
| Thailand | 1,693 | 64,865,5232 |
| Gall Bladder Cancer in Eastern Europe (Extrapolated Statistics) | ||
| Azerbaijan | 205 | 7,868,3852 |
| Belarus | 269 | 10,310,5202 |
| Bulgaria | 196 | 7,517,9732 |
| Estonia | 35 | 1,341,6642 |
| Georgia | 122 | 4,693,8922 |
| Kazakhstan | 395 | 15,143,7042 |
| Latvia | 60 | 2,306,3062 |
| Lithuania | 94 | 3,607,8992 |
| Romania | 583 | 22,355,5512 |
| Russia | 3,758 | 143,974,0592 |
| Slovakia | 141 | 5,423,5672 |
| Slovenia | 52 | 2,011,473 2 |
| Tajikistan | 183 | 7,011,556 2 |
| Ukraine | 1,245 | 47,732,0792 |
| Uzbekistan | 689 | 26,410,4162 |
| Gall Bladder Cancer in Australasia and Southern Pacific (Extrapolated Statistics) | ||
| Australia | 519 | 19,913,1442 |
| New Zealand | 104 | 3,993,8172 |
| Gall Bladder Cancer in the Middle East (Extrapolated Statistics) | ||
| Afghanistan | 744 | 28,513,6772 |
| Egypt | 1,986 | 76,117,4212 |
| Gaza strip | 34 | 1,324,9912 |
| Iran | 1,762 | 67,503,2052 |
| Iraq | 662 | 25,374,6912 |
| Israel | 161 | 6,199,0082 |
| Jordan | 146 | 5,611,2022 |
| Kuwait | 58 | 2,257,5492 |
| Lebanon | 98 | 3,777,2182 |
| Libya | 147 | 5,631,5852 |
| Saudi Arabia | 673 | 25,795,9382 |
| Syria | 470 | 18,016,8742 |
| Turkey | 1,798 | 68,893,9182 |
| United Arab Emirates | 65 | 2,523,9152 |
| West Bank | 60 | 2,311,2042 |
| Yemen | 522 | 20,024,8672 |
| Gall Bladder Cancer in South America (Extrapolated Statistics) | ||
| Belize | 7 | 272,9452 |
| Brazil | 4,805 | 184,101,1092 |
| Chile | 413 | 15,823,9572 |
| Colombia | 1,104 | 42,310,7752 |
| Guatemala | 372 | 14,280,5962 |
| Mexico | 2,739 | 104,959,5942 |
| Nicaragua | 139 | 5,359,7592 |
| Paraguay | 161 | 6,191,3682 |
| Peru | 718 | 27,544,3052 |
| Puerto Rico | 101 | 3,897,9602 |
| Venezuela | 653 | 25,017,3872 |
| Gall Bladder Cancer in Africa (Extrapolated Statistics) | ||
| Angola | 286 | 10,978,5522 |
| Botswana | 42 | 1,639,2312 |
| Central African Republic | 97 | 3,742,4822 |
| Chad | 248 | 9,538,5442 |
| Congo Brazzaville | 78 | 2,998,0402 |
| Congo kinshasa | 1,522 | 58,317,0302 |
| Ethiopia | 1,862 | 71,336,5712 |
| Ghana | 541 | 20,757,0322 |
| Kenya | 860 | 32,982,1092 |
| Liberia | 88 | 3,390,6352 |
| Niger | 296 | 11,360,5382 |
| Nigeria | 463 | 12,5750,3562 |
| Rwanda | 215 | 8,238,6732 |
| Senegal | 283 | 10,852,1472 |
| Sierra leone | 153 | 5,883,8892 |
| Somalia | 216 | 8,304,6012 |
| Sudan | 1,021 | 39,148,1622 |
| South Africa | 1,160 | 44,448,4702 |
| Swaziland | 30 | 1,169,2412 |
| Tanzania | 941 | 36,070,7992 |
| Uganda | 688 | 26,390,2582 |
| Zambia | 287 | 11,025,6902 |
| Zimbabwe | 95 | 1,2671,8602 |
Footnotes:
1. US Census Bureau, Population Estimates, 2004
2. US Census Bureau, International Data Base, 2004
Medical Tools & Articles:
Next articles:
Medical Articles: